Almontys, Headline

Almonty's Headline Profit Masks a Mine Still Finding Its Feet

Published on 11/21/2026 at 05:20 | Editorial boerse-global.de
Almonty's Q3 net profit of C$50.2M was mostly non-cash gains; adjusted EBITDA hit C$14.6M as a US$67M Canadian lawsuit and sliding shares weigh.
Almontys, Headline, Profit, Masks, Mine, Still, Finding, Its, Feet, C$502M Illustration mit AI erstellt.

Almonty Industries booked a net profit of C$50.2 million for the third quarter of 2026, but the figure owes almost all of its weight to accounting rather than ore. Non-cash gains from the revaluation of derivatives and warrants accounted for C$47.9 million of that total — paper gains that lift reported earnings without putting a single dollar in the company's coffers. Strip them out and the picture shifts to a more modest operating story, one now shadowed by a Canadian lawsuit and a share price that has been sliding.

The stock fell 16% on Friday, a day after a 15% drop to €5.87, as investors weighed the legal dispute against the company's progress at its flagship tungsten project.

Operating Yardstick Tells a Different Story

For judging the underlying business, adjusted EBITDA is the more telling measure. It came in at C$14.6 million for the quarter, on revenue of C$41.9 million — a 382% jump from the same period a year earlier. That said, EBITDA does not reveal how much cash actually remains after capital spending and financing costs, so its trajectory across several reporting periods matters more than any single strong quarter.

Sangdong, Almonty's tungsten mine, produced its first tungsten concentrate in September. After the quarter closed, the first container of concentrate was loaded in Busan. Both the initial production and the inaugural shipment are now documented — but neither proves regular deliveries or the revenue contribution they might bring. Whether additional shipments translate into a stronger operating result cannot be read from revenue growth alone.

Should investors sell immediately? Or is it worth buying Almonty?

Analysts Trim Targets but Keep the Faith

The analyst community has not abandoned the stock, though it has grown more cautious on timing. GBC recommended the shares as a buy on Thursday with a price target of US$30 for December 31, 2027, while factoring in technical challenges at Sangdong and pushing its expected production ramp-up back by roughly three quarters. Sphene Capital cut its target from US$26.40 to US$22.40 on November 16, keeping its buy rating. Stifel lowered its target from US$21 to US$18 on November 13, also maintaining a buy.

The bullish case, then, does not rest on an unchanged ramp-up schedule. A price target remains a forecast, not evidence that the anticipated operating gains will materialize.

A Courtroom Claim That Operations Cannot Fix

Separately, Deutsche Rohstoff disclosed on November 11 that it has sued Almonty in Canada for around US$67 million, citing disputed claims arising from alleged breaches of contract. The claim covers rights to 3.5 million conversion shares as well as the repayment of debt. Almonty has filed its own suit against Deutsche Rohstoff, and the two proceedings have been consolidated.

Consolidation does not settle the merits. For valuation purposes, neither the full claim should be booked as a certain liability nor a favorable outcome assumed. Unlike the production ramp-up, no improvement in operating numbers can dispel this uncertainty.

Korea Listing and the Next Data Point

Almonty is also pursuing a secondary listing on the Korea Exchange, subject to approval from the exchange and regulators, suitable market conditions and compliance with securities rules.

On the operational front, the next concrete checkpoint would be news of another concentrate shipment from Sangdong, which could demonstrate progress at the mine. Whether that translates into greater earning power would only become clear in subsequent financial reports. For investors, these are two distinct questions: is Sangdong shipping more, and is that improving the operating result? If deliveries keep coming and adjusted EBITDA eventually reflects the advance, the case for a broader earnings base gains credibility. If the ramp-up stalls or additional shipments fail to move the operating line, that case weakens.

Ad

Almonty Stock: New Analysis - 21 November

Fresh Almonty information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Almonty analysis...

Disclaimer...
en | CA0203987072 | ALMONTYS | boerse | 70541355 |